HLA-A*11 was detected to predispose worse outcome of COVID-19 patients (Lorente et al., 2021), while another study suggested that HLA-A*11:01 could generate efficient antiviral responses (Tomita et al., 2020). This evidence concerns the gene HLA-A and COVID-19.